June 25 (Reuters) - China's Sinovac Biotech said on Saturday that South Africa's health products regulator has granted conditional registration to its coronavirus vaccine CoronaVac for people aged 18 and above. (Reporting by Akanksha Khushi in Bengaluru; Editing by Sam Holmes)
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.47 USD | -0.31% | -.--% | -.--% |
11:45am | Pentagon ran secret anti-vax campaign to undermine China during pandemic | RE |
Apr. 29 | Sinovac Biotech Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
2,017 PTS | +1.47% | +1.86% | - | ||
457.1 PTS | -0.11% | -1.16% | - | ||
156.4 PTS | -0.10% | -1.24% | - | ||
1st Jan change | Capi. | |
---|---|---|
-.--% | 642M | |
+0.85% | 92.4B | |
-3.16% | 38.08B | |
-10.63% | 34.05B | |
+75.35% | 27.77B | |
-13.45% | 16B | |
-0.94% | 14.1B | |
-9.38% | 11.91B | |
+172.59% | 10.37B | |
-49.44% | 10.2B |
- Stock Market
- Equities
- SVA Stock
- News Sinovac Biotech Ltd.
- Sinovac's COVID-19 vaccine conditionally registered in South Africa